• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

METTL14 抑制 YAP1 的表达和三阴性乳腺癌的干性。

METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer.

机构信息

Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital of Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, 310003, Zhejiang, China.

Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.

出版信息

J Exp Clin Cancer Res. 2024 Nov 20;43(1):307. doi: 10.1186/s13046-024-03225-2.

DOI:10.1186/s13046-024-03225-2
PMID:39563370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11577812/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) has pronounced stemness that is associated with relapse. N-methyladenosine (mA) plays a crucial role in shaping cellular behavior by modulating transcript expression. However, the role of mA in TNBC stemness, as well as the mechanisms governing its abundance, has yet to be elucidated.

METHODS

We analyzed proteomic and transcriptomic data derived from breast cancer cohorts, with an emphasis on mA regulators. To unravel the role of mA in TNBC, we employed RNA sequencing, methylated RNA immunoprecipitation sequencing, RNA immunoprecipitation, chromatin immunoprecipitation, and luciferase reporter assays with mesenchymal stem-like (MSL) TNBC models. The clinical relevance was validated using human tissue microarrays and publicly accessible databases.

RESULTS

Our findings indicate that the global level of mA modification in MSL TNBC is downregulated primarily due to the loss of methyltransferase-like 14 (METTL14). The diminished mA modification is crucial for the maintenance of TNBC stemness, as it increases the expression of yes-associated protein 1 (YAP1) by blocking YTH domain-containing family protein 2 (YTHDF2)-mediated transcript decay, thereby promoting the activation of Hippo-independent YAP1 signaling. YAP1 is essential for sustaining the stemness regulated by METTL14. Furthermore, we demonstrated that the loss of METTL14 expression results from lysine-specific demethylase 1 (LSD1)-mediated removal of histone H3 lysine 4 methylation at the promoter region, which is critical for LSD1-driven stemness in TNBC.

CONCLUSION

These findings present an epi-transcriptional mechanism that maintains Hippo-independent YAP1 signaling and plays a role in preserving the undifferentiated state of TNBC, which indicates the potential for targeting the LSD1-METTL14 axis to address TNBC stemness.

摘要

背景

三阴性乳腺癌(TNBC)具有明显的干性,与复发相关。N6-甲基腺苷(mA)通过调节转录本表达在塑造细胞行为方面发挥着关键作用。然而,mA 在 TNBC 干性中的作用以及控制其丰度的机制尚未阐明。

方法

我们分析了来自乳腺癌队列的蛋白质组学和转录组学数据,重点关注 mA 调节因子。为了揭示 mA 在 TNBC 中的作用,我们采用了 RNA 测序、甲基化 RNA 免疫沉淀测序、RNA 免疫沉淀、染色质免疫沉淀和带有间充质干细胞样(MSL)TNBC 模型的荧光素酶报告基因检测。使用人组织微阵列和公开可访问的数据库验证了临床相关性。

结果

我们的研究结果表明,MSL TNBC 中 mA 修饰的整体水平主要由于甲基转移酶样 14(METTL14)的缺失而下调。mA 修饰的减少对于维持 TNBC 干性至关重要,因为它通过阻止 YTH 结构域家族蛋白 2(YTHDF2)介导的转录本降解来增加 YAP1 的表达,从而促进 Hippo 非依赖性 YAP1 信号的激活。YAP1 对于维持由 METTL14 调节的干性是必不可少的。此外,我们证明 METTL14 表达的缺失是由于赖氨酸特异性去甲基酶 1(LSD1)介导的启动子区域组蛋白 H3 赖氨酸 4 甲基化的去除所致,这对于 LSD1 驱动的 TNBC 干性至关重要。

结论

这些发现提出了一种表观转录机制,可维持 Hippo 非依赖性 YAP1 信号,并在维持 TNBC 的未分化状态中发挥作用,这表明靶向 LSD1-METTL14 轴可能是解决 TNBC 干性的一种策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/fce20fb4816e/13046_2024_3225_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/5ff54467df73/13046_2024_3225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/3bf77e2000b2/13046_2024_3225_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/8b6e0edd7f3f/13046_2024_3225_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/43bf450cd57b/13046_2024_3225_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/b322f3d71a41/13046_2024_3225_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/0acf175861a4/13046_2024_3225_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/fbb9054265b1/13046_2024_3225_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/fce20fb4816e/13046_2024_3225_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/5ff54467df73/13046_2024_3225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/3bf77e2000b2/13046_2024_3225_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/8b6e0edd7f3f/13046_2024_3225_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/43bf450cd57b/13046_2024_3225_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/b322f3d71a41/13046_2024_3225_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/0acf175861a4/13046_2024_3225_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/fbb9054265b1/13046_2024_3225_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be35/11577812/fce20fb4816e/13046_2024_3225_Fig8_HTML.jpg

相似文献

1
METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer.METTL14 抑制 YAP1 的表达和三阴性乳腺癌的干性。
J Exp Clin Cancer Res. 2024 Nov 20;43(1):307. doi: 10.1186/s13046-024-03225-2.
2
Knockdown of YAP1 Reduces YTHDF3 to Stabilize and thus Inhibit Bladder Cancer Stem Cell Stemness.敲低 YAP1 减少 YTHDF3 的表达,从而稳定并抑制膀胱癌干细胞的干性。
Discov Med. 2024 Jul;36(186):1486-1498. doi: 10.24976/Discov.Med.202436186.138.
3
Silencing of fibronectin type III domain-containing protein 3A (FNDC3A) attenuates epithelial-to-mesenchymal transition (EMT), cancer invasion, and stemness in triple-negative breast cancer (TNBC).沉默含III型纤连蛋白结构域蛋白3A(FNDC3A)可减弱三阴性乳腺癌(TNBC)中的上皮-间质转化(EMT)、癌症侵袭和干性。
Biochim Biophys Acta Mol Cell Res. 2025 Apr;1872(4):119935. doi: 10.1016/j.bbamcr.2025.119935. Epub 2025 Mar 20.
4
YAP1-induced RBM24 promotes the tumorigenesis of triple-negative breast cancer through the β-catenin pathway.YAP1 诱导的 RBM24 通过 β-catenin 通路促进三阴性乳腺癌的肿瘤发生。
J Investig Med. 2024 Jun;72(5):403-413. doi: 10.1177/10815589241239577. Epub 2024 Mar 22.
5
TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.TRIM58 下调通过 MYH9-GRK3-YAP 轴激活维持三阴性乳腺癌干细胞干性。
Cancer Gene Ther. 2024 Aug;31(8):1186-1200. doi: 10.1038/s41417-024-00780-w. Epub 2024 May 7.
6
DLAT promotes triple-negative breast cancer progression via YAP1 activation.DLAT 通过激活 YAP1 促进三阴性乳腺癌的进展。
Cancer Biol Ther. 2024 Dec 31;25(1):2421578. doi: 10.1080/15384047.2024.2421578. Epub 2024 Oct 26.
7
Triple‑negative breast cancer cell‑derived piR‑31115 promotes the proliferation and migration of endothelial cells via METTL3‑mediated m6A modification of YAP1.三阴性乳腺癌细胞衍生的piR-31115通过METTL3介导的YAP1的m6A修饰促进内皮细胞的增殖和迁移。
Oncol Rep. 2025 Mar;53(3). doi: 10.3892/or.2025.8867. Epub 2025 Jan 17.
8
Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747.甲基转移酶样蛋白 14 通过降低 LINC02747 的表达来抑制非小细胞肺癌的生长和转移。
Cancer Sci. 2024 Sep;115(9):2931-2946. doi: 10.1111/cas.16254. Epub 2024 Jun 18.
9
FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis.FOXP4 是 YAP1 的直接靶标,促进胃癌干细胞特性并驱动转移。
Cancer Res. 2024 Nov 4;84(21):3574-3588. doi: 10.1158/0008-5472.CAN-23-3074.
10
METTL14 attenuates cancer stemness by suppressing ATF5/WDR74/β-catenin axis in gastric cancer.METTL14通过抑制胃癌中的ATF5/WDR74/β-连环蛋白轴来减弱癌症干性。
Cancer Sci. 2025 Jan;116(1):112-127. doi: 10.1111/cas.16381. Epub 2024 Nov 4.

引用本文的文献

1
EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway.EPHA2通过AKT/PI3K/mTOR信号通路抑制细胞焦亡,从而促进三阴性乳腺癌进展。
Front Oncol. 2025 Aug 22;15:1620122. doi: 10.3389/fonc.2025.1620122. eCollection 2025.
2
Analysis of the mRNA modification machinery alterations in breast cancer through the SCAN-B cohort.通过SCAN-B队列分析乳腺癌中mRNA修饰机制的改变。
NAR Cancer. 2025 Sep 3;7(3):zcaf027. doi: 10.1093/narcan/zcaf027. eCollection 2025 Sep.
3
3D printing-biomimetic local stiff niche enhances glycolysis to boost PDAC cell stem-like phenotype via N6-methyladenosine-suppressed YAP1 mRNA decay.

本文引用的文献

1
mA modification negatively regulates translation by switching mRNA from polysome to P-body via IGF2BP3.mA 修饰通过 IGF2BP3 将 mRNA 从多核糖体切换到 P 体,从而负调控翻译。
Mol Cell. 2023 Dec 21;83(24):4494-4508.e6. doi: 10.1016/j.molcel.2023.10.040. Epub 2023 Nov 27.
2
PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma.PRMT3 介导的 METTL14 精氨酸甲基化促进子宫内膜癌的恶性进展和治疗抵抗。
Adv Sci (Weinh). 2023 Dec;10(36):e2303812. doi: 10.1002/advs.202303812. Epub 2023 Nov 16.
3
Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m A RNA methylation in ocular melanoma.
3D打印仿生局部硬壁龛通过N6-甲基腺苷抑制YAP1 mRNA衰变增强糖酵解,以促进胰腺导管腺癌细胞的干细胞样表型。
Mater Today Bio. 2025 Aug 5;34:102176. doi: 10.1016/j.mtbio.2025.102176. eCollection 2025 Oct.
4
The mA reader YTHDF3 promotes TNBC progression by regulating CENPI stabilization.毫安读数器YTHDF3通过调节CENPI的稳定性促进三阴性乳腺癌进展。
Front Oncol. 2025 May 8;15:1546723. doi: 10.3389/fonc.2025.1546723. eCollection 2025.
靶向组蛋白去乙酰化酶通过诱导眼黑素瘤中 METTL14 修饰的 mA RNA 甲基化抑制肿瘤生长。
Cancer Commun (Lond). 2023 Nov;43(11):1185-1206. doi: 10.1002/cac2.12471. Epub 2023 Jul 19.
4
LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism.长链非编码 RNA 通过调控 Hippo-YAP 信号通路来重编程铁代谢。
Nat Commun. 2023 Apr 20;14(1):2253. doi: 10.1038/s41467-023-37871-5.
5
METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity.METTL14 是一种独立于其 RNA N6-甲基腺苷甲基转移酶活性的染色质调节因子。
Protein Cell. 2023 Sep 14;14(9):683-697. doi: 10.1093/procel/pwad009.
6
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.新辅助治疗对三阴性乳腺癌患者的反应和长期生存的影响。
7
The oncogenic roles and clinical implications of YAP/TAZ in breast cancer.YAP/TAZ 在乳腺癌中的致癌作用及其临床意义。
Br J Cancer. 2023 May;128(9):1611-1624. doi: 10.1038/s41416-023-02182-5. Epub 2023 Feb 9.
8
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas.LATS1/2 的失活驱动管腔基底可塑性,引发基底样乳腺癌。
Nat Commun. 2022 Nov 28;13(1):7198. doi: 10.1038/s41467-022-34864-8.
9
METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.METTL14 介导的 MN1 mRNA 转录后修饰促进骨肉瘤的致瘤性和全反式维甲酸耐药性。
EBioMedicine. 2022 Aug;82:104142. doi: 10.1016/j.ebiom.2022.104142. Epub 2022 Jul 7.
10
YAP inhibits ERα and ER breast cancer growth by disrupting a TEAD-ERα signaling axis.YAP 通过破坏 TEAD-ERα 信号轴来抑制 ERα 和 ER 阳性乳腺癌的生长。
Nat Commun. 2022 Jun 2;13(1):3075. doi: 10.1038/s41467-022-30831-5.